The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Artificial intelligence for drug discovery: Resources, methods, and applications
Open accessAbstract
Conventional wet laboratory testing, validations, and synthetic procedures are costly and time-consuming for drug discovery. Advancements in artificial intelligence (AI) techniques have revolutionized their applications to drug discovery. Combined with accessible data resources, AI techniques are changing the landscape of drug discovery. In the past decades, a series of AI-based models have been developed for various steps of drug discovery. These models have been used as complements of conventional experiments and have accelerated the drug discovery process. In this review, we first introduced the widely used data resources in drug discovery, such as ChEMBL and DrugBank, followed by the molecular representation schemes that convert data into computer-readable formats. Meanwhile, we summarized the algorithms used to develop AI-based models for drug discovery. Subsequently, we discussed the applications of AI techniques in pharmaceutical analysis including predicting drug toxicity, drug bioactivity, and drug physicochemical property. Furthermore, we introduced the AI-based models for de novo drug design, drug-target structure prediction, drug-target interaction, and binding affinity prediction. Moreover, we also highlighted the advanced applications of AI in drug synergism/antagonism prediction and nanomedicine design. Finally, we discussed the challenges and future perspectives on the applications of AI to drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
PyTorch: An Imperative Style, High-Performance Deep Learning Library
Paszke, A., Gross, S., Massa, F., Lerer, A., Bradbury, J., Chanan, G., Killeen, T., Lin, Z., Gimelshein, N., Antiga, L., et al. (2019) · arXiv · doi:10.48550/arxiv.1912.01703 · Cited by 31,473
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,939
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1074 · Cited by 8,056 · cited 1×
“The Search Tool for Interacting Chemicals (STITCH) is a database that contains known and predicted interactions between chemicals and proteins.(16) These interactions encompass 9,643,763 proteins from 2,031 organisms, which were collected from computational prediction, knowledge transfer between organisms, and other d…”
BackgroundExtended-Connectivity Fingerprints
Rogers, D., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,524
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · cited 7×
“Apart from the property-based 1D descriptor, the simpli fi ed molecular-input line-entry system (SMILES) 21 is another type of 1D descriptor.”
MethodInfluentialCancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
PubChem in 2021: new data content and improved web interfaces
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa971 · Cited by 3,953
Improved protein structure prediction using potentials from deep learning
Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., Qin, C., Žídek, A., Nelson, A. W. R., Bridgland, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1923-7 · Cited by 3,378
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359 · cited 1×
“56 To address these challenges, AI techniques have been applied to nearly all aspects of drug discovery.”
MethodApplications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
ChEMBL: towards direct deposition of bioassay data
Mendez, D., Gaulton, A., Bento, A. P., Chambers, J., De Veij, M., Félix, E., Magariños, M. P., Mosquera, J. F., Mutowo, P., Nowotka, M., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1075 · Cited by 2,372
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.
Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,703
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Ozkirimli, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,696
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,182
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081 · cited 2×
“49 After performing data cleaning and quality control, the remaining chemicals are encoded by using the aforementioned 0D to 3D molecular descriptors, which are used as input of DNN.”
MethodCombinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070 · cited 1×
“Other applications of AI to nanomedicine design and their principles were summarized in a recent comprehensive review.(80)”
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018 · cited 1×
“Some major pharmaceutical companies, such as Bayer, Roche, and Pfizer, have also begun to collaborate with information technology (IT) companies to develop AI technique-based methods for drug design.(6) Recently, with the help of AI, the Insilico Medicine company discovered the drug treating idiopathic pulmonary fibro…”
BackgroundIntegration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts
Freshour, S. L., Kiwala, S., Cotto, K. C., Coffman, A. C., McMichael, J. F., Song, J. J., Griffith, M., Griffith, O. L., & Wagner, A. H. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1084 · Cited by 998
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Machine Learning in Drug Discovery: A Review
Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 792
In silico toxicology: computational methods for the prediction of chemical toxicity
Raies, A. B., & Bajic, V. B. (2016) · WIREs Computational Molecular Science · doi:10.1002/wcms.1240 · Cited by 744
Lee, I., Keum, J., & Nam, H. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007129 · Cited by 675
COCONUT online: Collection of Open Natural Products database
Sorokina, M., Merseburger, P., Rajan, K., Yirik, M. A., & Steinbeck, C. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-020-00478-9 · Cited by 665
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 653
Molecular representations in AI-driven drug discovery: a review and practical guide
David, L., Thakkar, A., Mercado, R., & Engkvist, O. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00460-5 · Cited by 587 · cited 1×
“17 Various types of descriptors have been proposed to represent drugs; these descriptors can be classi fi ed into four categories in accordance with their dimensionality (Figure 2).”
BackgroundDeep-Learning-Based Drug–Target Interaction Prediction
Wen, M., Zhang, Z., Niu, S., Sha, H., Yang, R., Yun, Y., & Lu, H. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00618 · Cited by 576
Toward more realistic drug-target interaction predictions
Pahikkala, T., Airola, A., Pietila, S., Shakyawar, S., Szwajda, A., Tang, J., & Aittokallio, T. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbu010 · Cited by 559
How artificial intelligence is changing drug discovery
Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546 · cited 1×
“8 billion and 15 years on average.(1) The lowefficacy and high-cost characteristics of conventional methods have become the hurdles of drug discovery.”
BackgroundKarimi, M., Wu, D., Wang, Z., & Shen, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz111 · Cited by 536
He, T., Heidemeyer, M., Ban, F., Cherkasov, A., & Ester, M. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0209-z · Cited by 509
‘It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures
Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-03348-4 · Cited by 499
REINVENT 2.0: An AI Tool for De Novo Drug Design
Blaschke, T., Arús-Pous, J., Chen, H., Margreitter, C., Tyrchan, C., Engkvist, O., Papadopoulos, K., & Patronov, A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00915 · Cited by 496
Generative Recurrent Networks for De Novo Drug Design
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700111 · Cited by 441
Artificial intelligence in cancer target identification and drug discovery
You, Y., Lai, X., Pan, Y., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 435
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Logistic Regression in Medical Research
Schober, P., & Vetter, T. R. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005247 · Cited by 395
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
Guengerich, F. P. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-062 · Cited by 387
Multi-objective de novo drug design with conditional graph generative model
Li, Y., Zhang, L., & Liu, Z. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0287-6 · Cited by 376
ChemmineR: a compound mining framework for R
Cao, Y., Charisi, A., Cheng, L.-C., Jiang, T., & Girke, T. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn307 · Cited by 374
Artificial Intelligence for Drug Toxicity and Safety
Basile, A. O., Yahi, A., & Tatonetti, N. P. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.005 · Cited by 363
One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome
Capecchi, A., Probst, D., & Reymond, J.-L. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00445-4 · Cited by 363
Advances in De Novo Drug Design: From Conventional to Machine Learning Methods
Mouchlis, V. D., Afantitis, A., Serra, A., Fratello, M., Papadiamantis, A. G., Aidinis, V., Lynch, I., Greco, D., & Melagraki, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041676 · Cited by 353
Yang, H., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00030 · Cited by 280
Deep learning methods for molecular representation and property prediction
Li, Z., Jiang, M., Wang, S., & Zhang, S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103373 · Cited by 279
Self-citationA Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.001 · Cited by 212
Large-scale exploration and analysis of drug combinations
Li, P., Huang, C., Fu, Y., Wang, J., Wu, Z., Ru, J., Zheng, C., Guo, Z., Chen, X., Zhou, W., et al. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv080 · Cited by 195
Prediction of drug efficacy from transcriptional profiles with deep learning
Zhu, J., Wang, J., Wang, X., Gao, M., Guo, B., Gao, M., Liu, J., Yu, Y., Wang, L., Kong, W., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00946-z · Cited by 193 · cited 1×
“prediction system (DLEPS) that can identify drug candidates in accordance with the changes in gene expression profiles rather than specific targets.(75) First, compounds were encoded using SMILES and used as input of CNN to fit gene expression changes.”
MethodMachine learning predicts 3D printing performance of over 900 drug delivery systems
Muñiz Castro, B., Elbadawi, M., Ong, J. J., Pollard, T., Song, Z., Gaisford, S., Pérez, G., Basit, A. W., Cabalar, P., & Goyanes, A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.046 · Cited by 193
ChemDB: a public database of small molecules and related chemoinformatics resources
Chen, J., Swamidass, S. J., Dou, Y., Bruand, J., & Baldi, P. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti683 · Cited by 186
Deep learning approaches for de novo drug design: An overview
Wang, M., Wang, Z., Sun, H., Wang, J., Shen, C., Weng, G., Chai, X., Li, H., Cao, D., & Hou, T. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.10.001 · Cited by 184
Shen, M., Xiao, Y., Golbraikh, A., Gombar, V. K., & Tropsha, A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020491t · Cited by 183
Graph networks for molecular design
Mercado, R., Rastemo, T., Lindelöf, E., Klambauer, G., Engkvist, O., Chen, H., & Jannik Bjerrum, E. (2021) · Machine Learning: Science and Technology · doi:10.1088/2632-2153/abcf91 · Cited by 183
Deep learning tools for advancing drug discovery and development
Nag, S., Baidya, A. T. K., Mandal, A., Mathew, A. T., Das, B., Devi, B., & Kumar, R. (2022) · 3 Biotech · doi:10.1007/s13205-022-03165-8 · Cited by 174
Tang, J. P., Tanoli, Z., Ravikumar, B., Alam, Z., Rebane, A., Vähä-Koskela, M. J. V., Peddinti, G., van Adrichem, A. J., Wakkinen, J., Jaiswal, A., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.11.009 · Cited by 168
Drugs derived from phage display: From candidate identification to clinical practice
Nixon, A. E., Sexton, D. J., & Ladner, R. C. (2014) · mAbs · doi:10.4161/mabs.27240 · Cited by 167
In silico prediction of toxicity and its applications for chemicals at work
Rim, K.-T. (2020) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-020-00056-4 · Cited by 158
Oligonucleotide Therapeutics: From Discovery and Development to Patentability
Moumné, L., Marie, A.-C., & Crouvezier, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020260 · Cited by 158
WideDTA: prediction of drug-target binding affinityPreprint
Öztürk, H., Özkırımlı, E., & Özgür, A. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1902.04166 · Cited by 150
Advances with support vector machines for novel drug discovery
Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R., & Honório, K. M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1549033 · Cited by 134
Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning
Wildenhain, J., Spitzer, M., Dolma, S., Jarvik, N., White, R., Roy, M. M., Griffiths, E., Bellows, D. S., Wright, G. D., & Tyers, M. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.003 · Cited by 132
Deep Learning-Based Advances in Protein Structure Prediction
Pakhrin, S. C., Shrestha, B., Adhikari, B., & KC, D. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115553 · Cited by 129
Comparing 3D Pharmacophore Triplets and 2D Fingerprints for Selecting Diverse Compound Subsets
Matter, H., & Pötter, T. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980185h · Cited by 117
Prediction of Adverse Drug Reactions Using Decision Tree Modeling
Hammann, F., Gutmann, H., Vogt, N., Helma, C., & Drewe, J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.248 · Cited by 115
Molecular Descriptors for Structure–Activity Applications: A Hands-On Approach
Grisoni, F., Ballabio, D., Todeschini, R., & Consonni, V. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7899-1_1 · Cited by 111
Wood, D. J., de Vlieg, J., Wagener, M., & Ritschel, T. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3000776 · Cited by 108
Li, Y., Abbaspour, M., Grootendorst, P. V., Rauth, A. M., & Wu, X. Y. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.04.028 · Cited by 105
Yeast two-hybrid methods and their applications in drug discovery
Hamdi, A., & Colas, P. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.10.008 · Cited by 103
Machine Learning in Drug Discovery and Development Part 1: A Primer
Talevi, A., Morales, J. F., Hather, G. J., Podichetty, J. T., Kim, S., Bloomingdale, P., Kim, S., Burton, J. K., Brown, J. D., Winterstein, A. G., et al. (2020) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12491 · Cited by 102
Alafeef, M., Srivastava, I., & Pan, D. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00329 · Cited by 101
Interpretable clinical prediction via attention-based neural network
Chen, P., Dong, W., Wang, J.-L., Lü, X., Kaymak, U., & Huang, Z. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-1110-7 · Cited by 101
HobPre: accurate prediction of human oral bioavailability for small molecules
Wei, M., Zhang, X., Pan, X., Wang, B., Ji, C., Qi, Y., & Zhang, J. Z. H. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-021-00580-6 · Cited by 96
Evaluation of Deep Learning Architectures for Aqueous Solubility Prediction
Panapitiya, G., Girard, M., Hollas, A., Sepulveda, J., Murugesan, V., Wang, W., & Saldanha, E. (2022) · ACS Omega · doi:10.1021/acsomega.2c00642 · Cited by 96
Tang, Q., Nie, F., Zhao, Q., & Chen, W. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac357 · Cited by 96
Self-citationUsing GANs with adaptive training data to search for new molecules
Blanchard, A. E., Stanley, C. B., & Bhowmik, D. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00494-3 · Cited by 94
Prediction of small-molecule compound solubility in organic solvents by machine learning algorithms
Ye, Z., & Ouyang, D. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00575-3 · Cited by 91
Fast screening of protein surfaces using geometric invariant fingerprints
Yin, S., Proctor, E. A., Lugovskoy, A. A., & Dokholyan, N. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906146106 · Cited by 90
Multiobjective de novo drug design with recurrent neural networks and nondominated sorting
Yasonik, J. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00419-6 · Cited by 80
INPUT: An intelligent network pharmacology platform unique for traditional Chinese medicine
Li, X., Tang, Q., Meng, F., Du, P.-F., & Chen, W. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.006 · Cited by 75
Self-citationChemical space exploration guided by deep neural networks
Karlov, D. S., Sosnin, S., Tetko, I. V., & Fedorov, M. V. (2019) · RSC Advances · doi:10.1039/c8ra10182e · Cited by 71
Seo, M., Shin, H. K., Myung, Y., Hwang, S., & No, K. T. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-0410-3 · Cited by 71
Emerging Computational Approaches for Antimicrobial Peptide Discovery
Agüero-Chapin, G., Cańizares, D. G., Domínguez‐Pérez, D., Marrero‐Ponce, Y., Pérez-Machado, G., Teijeira, M., & Antunes, A. (2022) · Antibiotics · doi:10.3390/antibiotics11070936 · Cited by 70
Emerging biotechnology applications in natural product and synthetic pharmaceutical analyses
Chen, S., Li, Z., Zhang, S., Zhou, Y., Xiao, X., Cui, P., Xu, B., Zhao, Q., Kong, S., & Dai, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.025 · Cited by 65
Self-citationChiba, S., Lim, K. R. Q., Sheri, N., Anwar, S., Erkut, E. J. N., Shah, M. N. A., Aslesh, T., Woo, S., Sheikh, O., Maruyama, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab442 · Cited by 63
The applications of PCA in QSAR studies: A case study on CCR5 antagonists
Yoo, C., & Shahlaei, M. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13064 · Cited by 61
The Potential of HIV-1 Nanotherapeutics: from in vitro Studies to Clinical Trials
Roy, U. B., Rodríguez, J. C. D., Barber, P., das Neves, J., Sarmento, B. F. C. C., & Nair, M. (2015) · Nanomedicine · doi:10.2217/nnm.15.160 · Cited by 57
Covell, D. G., Huang, R., & Wallqvist, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0787 · Cited by 57
SMEpred workbench: A web server for predicting efficacy of chemicallymodified siRNAs
Dar, S. A., Gupta, A., Thakur, A., & Kumar, M. (2016) · RNA Biology · doi:10.1080/15476286.2016.1229733 · Cited by 57
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2
Huang, R., Xu, M., Zhu, H., Chen, C. Z., Zhu, W. J., Lee, E. M., He, S., Zhang, L., Zhao, J., Shamim, K., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00839-1 · Cited by 54
Erratum: Generative Recurrent Networks for De Novo Drug Design.
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201880141 · Cited by 40
El-Attar, N. E., Hassan, M. K., Alghamdi, O. A., & Awad, W. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-78449-1 · Cited by 28
“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool
Manelfi, C., Gemei, M., Talarico, C., Cerchia, C., Fava, A., Lunghini, F., & Beccari, A. R. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00526-y · Cited by 23
Current Clinical Treatments of AIDS
Murphy, E., Jimenez, H. R., & Smith, S. M. (2008) · Advances in pharmacology · doi:10.1016/s1054-3589(07)56002-3 · Cited by 13
Husain, A., Begum, N. A., Kobayashi, M., et al. (2020) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3837 · Cited by 7
Research works printed but not linked: 1
- Öztürk, 2019, WideDTA: prediction of drugtarget binding affinity, arXiv
Cited by
Explainable artificial intelligence for drug discovery and development: a comprehensive survey
Alizadehsani, R., Oyelere, S. S., Hussain, S., Jagatheesaperumal, S. K., Calixto, R. R., Rahouti, M., Roshanzamir, M., & De Albuquerque, V. H. C. (2024) · IEEE Access · doi:10.1109/access.2024.3373195 · Cited by 124
Ogut, E. (2025) · Clinics and Practice · doi:10.3390/clinpract15090169 · Cited by 107
The impact of AI on modern oncology from early detection to personalized cancer treatment
Li, J., Zhang, L., Yu, Z., Bao, Z., Li, D., & Wang, L. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01276-6 · Cited by 24
Metadata
- Authors
- Chen, W., Liu, X., Zhang, S., & Chen, S.
- Venue
- Molecular Therapy - Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 31
- Pages
- 691-702
- ISSN
- 2162-2531 (ISSN-L)
- OpenAlex
- W4321254242
- Cited by
- 273
- References
- 100
- FWCI
- 36.06
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Natural Science Foundation of Sichuan Province (2023NSFSC0683)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.